Is a complete AARD research report available?

No complete published report is available for Aardvark Therapeutics, Inc. (AARD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Aardvark Therapeutics, Inc. (AARD)

NASDAQ: AARD · USD

$1.58

+0.28 (+21.5%)· Recorded snapshot

Market cap	34.6M
Net income (ttm)	-69.9M
EPS (ttm)	-$3.20
Shares out	21.9M
Volume	1,915,964

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -69.9M
EPS (ttm): -$3.20
Market cap: 34.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Metric	Value
Amount currency	USD
CIK code	0001774857
Company name	Aardvark Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	002942100
Earnings date	2026-11-12
Earnings time	amc
Employees	28
Employees change	-3
Employees growth	-9.68%
Enterprise value	$-38.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
Industry	Biotechnology
IPO date	2025-02-13
Is primary listing	Yes
Is SPAC	No
ISIN number	US0029421007
Last 10-K release date	2026-03-23
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$34.6M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$1.58
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	AARD
U.S. state	California
Website	https://aardvarktherapeutics.com

Metric

Value

Amount currency

USD

CIK code

0001774857

Company name

Aardvark Therapeutics, Inc.

Country

United States

Country code

CUSIP number

002942100

Earnings date

2026-11-12

Earnings time

amc

Employees

Employees change

-3

Employees growth

-9.68%

Enterprise value

$-38.6M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2017

Industry

Biotechnology

IPO date

2025-02-13

Is primary listing

Yes

Is SPAC

ISIN number

US0029421007

Last 10-K release date

2026-03-23

Last earnings date

2026-08-11

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$34.6M

Market cap category

Nano-Cap

Next earnings date

2026-11-12

Options

Yes

Price

$1.58

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

AARD

U.S. state

California

Website

https://aardvarktherapeutics.com

Metric	Value
Earnings yield	-202.84%
FCF / EV yield	175.77%
FCF yield	-205.95%
P/B ratio	0.38x
Price / tangible book value	0.45x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-202.84%

FCF / EV yield

175.77%

FCF yield

-205.95%

P/B ratio

0.38x

Price / tangible book value

0.45x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-2.5M
ROA	-40.38%
ROCE	-98.51%
ROE	-66.02%
ROIC	-43.39%

Metric

Value

Profit per employee

$-2.5M

ROA

-40.38%

ROCE

-98.51%

ROE

-66.02%

ROIC

-43.39%

Metric	Value
EPS growth years	1
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-4,000
Depreciation and amortization	$42,000
EBIT	$-74M
EBITDA	$-73.9M
EPS	$-3.20
FCF per share	$-3.17
Financing cash flow	$711,000
Free cash flow	$-69.4M
Free cash flow minus SBC	$-76.4M
Investing cash flow	$116.5M
Net cash flow	$47.9M
Net income	$-69.9M
Operating cash flow minus SBC	$-76.4M
Operating income	$-74M
Stock-based compensation	$7M

Metric

Value

Capital expenditures

$-4,000

Depreciation and amortization

$42,000

EBIT

$-74M

EBITDA

$-73.9M

EPS

$-3.20

FCF per share

$-3.17

Financing cash flow

$711,000

Free cash flow

$-69.4M

Free cash flow minus SBC

$-76.4M

Investing cash flow

$116.5M

Net cash flow

$47.9M

Net income

$-69.9M

Operating cash flow minus SBC

$-76.4M

Operating income

$-74M

Stock-based compensation

$7M

Metric	Value
Book value per share	$3.42
Debt / equity	0.01
Long-term assets	$799,000
Long-term liabilities	$276,000
Net cash (debt)	$73.2M
Net cash / market cap	217.17%
Net cash growth	-48.15%
Net debt / equity	-0.98
Piotroski F-Score	1
Property, plant and equipment	$626,000
Shareholders' equity	$74.8M
Tangible book value	$74.8M
Tangible book value per share	$3.42
Total assets	$81.5M
Total cash	$73.9M
Total debt	$677,000
Total liabilities	$6.7M

Metric

Value

Book value per share

$3.42

Debt / equity

0.01

Long-term assets

$799,000

Long-term liabilities

$276,000

Net cash (debt)

$73.2M

Net cash / market cap

217.17%

Net cash growth

-48.15%

Net debt / equity

-0.98

Piotroski F-Score

Property, plant and equipment

$626,000

Shareholders' equity

$74.8M

Tangible book value

$74.8M

Tangible book value per share

$3.42

Total assets

$81.5M

Total cash

$73.9M

Total debt

$677,000

Total liabilities

$6.7M

Metric	Value
Current assets	$80.7M
Current liabilities	$6.4M
Current ratio	12.63
Net working capital	$805,000
Quick ratio	11.57
Working capital	$74.3M

Metric

Value

Current assets

$80.7M

Current liabilities

$6.4M

Current ratio

12.63

Net working capital

$805,000

Quick ratio

11.57

Working capital

$74.3M

Metric	Value
Buyback yield / dilution	-102.94%
Dividend yield	0%
Shareholder yield	-102.94%

Metric

Value

Buyback yield / dilution

-102.94%

Dividend yield

Shareholder yield

-102.94%

Metric	Value
150-day SMA	$5.14
1D price change	21.54%
1M price change	-71.54%
1M total return	-71.54%
1W price change	-63.08%
1W total return	-63.08%
1Y price change	-87.68%
1Y return CAGR	-87.7%
1Y total return	-87.68%
20-day SMA	$3.81
200-day SMA	$6.46
3M price change	-78.48%
3M total return	-78.48%
50-day SMA	$4.97
50-day SMA vs 200-day SMA	50under200
52-week high	$16.60
52-week high date	2026-01-22
52-week low	$0.93
52-week low date	2026-10-26
6M price change	-73.91%
6M total return	-73.91%
All-time high	$19.58
All-time high date	2025-02-20
All-time low	$0.93
All-time low date	2026-10-26
Average true range (ATR)	$0.58
Average volume	1.5M
Beta (1Y)	4.8
Beta (2Y)	2.56
Change from 52-week high	-90.48%
Change from 52-week low	69.89%
Change from all-time high	-92.65%
Change from all-time low	54.84%
Change from open	28.46%
Day's gap	-5.38%
Dollar volume	$3M
High price	$1.58
Low price	$1.19
Monthly RSI	38.86
Open price	$1.23
Position in 52-week range	100%
Premarket change	-0.77%
Premarket close	$1.30
Premarket price	$1.29
Premarket volume	37.5K
Previous close	$1.30
Price vs 150-day SMA	-71.97%
Price vs 20-day SMA	-62.19%
Price vs 200-day SMA	-77.7%
Price vs 50-day SMA	-71.02%
Relative volume	1.25
Return from IPO open	-89.86%
Return from IPO price	-90.38%
RSI	24.66
Sharpe ratio	-0.55
Sortino ratio	-0.66
Volume	1.9M
Weekly RSI	29.76
YTD price change	-89.03%
YTD total return	-89.03%

Metric

Value

150-day SMA

$5.14

1D price change

21.54%

1M price change

-71.54%

1M total return

-71.54%

1W price change

-63.08%

1W total return

-63.08%

1Y price change

-87.68%

1Y return CAGR

-87.7%

1Y total return

-87.68%

20-day SMA

$3.81

200-day SMA

$6.46

3M price change

-78.48%

3M total return

-78.48%

50-day SMA

$4.97

50-day SMA vs 200-day SMA

50under200

52-week high

$16.60

52-week high date

2026-01-22

52-week low

$0.93

52-week low date

2026-10-26

6M price change

-73.91%

6M total return

-73.91%

All-time high

$19.58

All-time high date

2025-02-20

All-time low

$0.93

All-time low date

2026-10-26

Average true range (ATR)

$0.58

Average volume

1.5M

Beta (1Y)

4.8

Beta (2Y)

2.56

Change from 52-week high

-90.48%

Change from 52-week low

69.89%

Change from all-time high

-92.65%

Change from all-time low

54.84%

Change from open

28.46%

Day's gap

-5.38%

Dollar volume

$3M

High price

$1.58

Low price

$1.19

Monthly RSI

38.86

Open price

$1.23

Position in 52-week range

100%

Premarket change

-0.77%

Premarket close

$1.30

Premarket price

$1.29

Premarket volume

37.5K

Previous close

$1.30

Price vs 150-day SMA

-71.97%

Price vs 20-day SMA

-62.19%

Price vs 200-day SMA

-77.7%

Price vs 50-day SMA

-71.02%

Relative volume

1.25

Return from IPO open

-89.86%

Return from IPO price

-90.38%

RSI

24.66

Sharpe ratio

-0.55

Sortino ratio

-0.66

Volume

1.9M

Weekly RSI

29.76

YTD price change

-89.03%

YTD total return

-89.03%

Metric	Value
Float	11M
Float percentage	50.3%
Shares change (QoQ)	0.14%
Shares change (YoY)	102.94%
Shares held by insiders	15.96%
Shares held by institutions	19.41%
Shares outstanding	21.9M
Short % of float	4.31%
Short % of shares	2.17%
Short ratio	3.9 days

Metric

Value

Float

11M

Float percentage

50.3%

Shares change (QoQ)

0.14%

Shares change (YoY)

102.94%

Shares held by insiders

15.96%

Shares held by institutions

19.41%

Shares outstanding

21.9M

Short % of float

4.31%

Short % of shares

2.17%

Short ratio

3.9 days

Aardvark Therapeutics, Inc. (AARD)

Price

Financial snapshot

Fair-value bridge

Latest news · AARD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AARD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AARD

Frequently asked questions